Automated Pap Smears Effect On Medicare Costs To Be Examined By IoM
This article was originally published in The Gray Sheet
Executive SummaryThe impact of automated Pap smear technology is among recent trends in the clinical lab industry that will be evaluated by a 12-member Institute of Medicine committee in a 15-month study of Medicare payment methods for laboratory tests.
You may also be interested in...
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.